COVID-19 antibody therapy set up on Texas A&M University campus

September 24, 2021, 2:15 p.m. CDT

A COVID-19 mobile therapeutic infusion center is now available on the Texas A&M University campus for certain individuals who test positive with the virus and have a referral from a doctor.

A mobile team from the Texas Division of Emergency Management is administering infusions across the community and is based at Student Health Services, located at the A.P. Beutel Health Center across from All Faiths Chapel and Sbisa Dining Hall.

Take the following steps:

  • Have your physician submit an order to the State of Texas Infusion Hotline website.
  • TDEM staff will then contact the patient to arrange a time for the infusion.
  • Eligible students, faculty and staff who do not have a primary care physician may request this therapy by going to the Student Health Services website https://tx.ag/mabt to submit a request

The purpose of the antibody therapy is to reduce the chances of developing serious symptoms that require hospitalization. It works best when it's given early, which means within a few days of a positive COVID-19 test. If symptoms become severe, and you require hospitalization, you may no longer be eligible to receive this form of therapy.

Locations across the state:

These state-supported mobile infusion units are offered in addition to the antibody infusion treatments being provided by more than 200 private health providers across the state. Texas A&M students, faculty and staff outside of College Station can visit meds.tdem.texas.gov to find a therapeutic provider near them.

Eligibility requirements include:

  • Patient is symptomatic and has mild to moderate illness as noted by the following criteria:
  • Is not hospitalized due to COVID-19;
  • Does not require oxygen therapy due to COVID-19 and has a saturation of oxygen greater than or equal to 94 percent on room air at sea level; or
  • Patient is at Day 10 or less since symptoms started or since testing positive.
  • Pregnant individuals must be cleared by an OB/GYN physician before getting an infusion.

Ineligible individuals who fall into any of the below categories include:

  • Symptoms onset or initial positive COVID test more than 10 days ago;
  • Oxygen percent (if known) is lower than 93 percent on room air;
  • If on oxygen chronically, is on same rate;
  • Weight is less than 88 pounds;
  • Stable for home management care;
  • Too ill for home management care; and
  • If the individual doesn't have proof of a positive COVID test.

The FDA granted emergency use authorization for the new treatments for COVID-19, known as monoclonal antibodies, and have been approved to treat non-hospitalized adults and children over age 12.

How does it work?

Monoclonal antibodies are lab-produced molecules that act as substitute antibodies to restore, enhance or mimic the immune system's function to attack foreign cells, which in this case is the COVID-19 virus. The treatments attack the COVID-19 protein, making it more difficult for the virus to attach and enter human cells. 

Resources

Gov. Greg Abbott, TDEM and the Texas Department of State Health Services (DSHS) established and expanded antibody infusion centers in communities across the state over the past several months.

These facilities, listed on this site, also help increase bed capacity in hospitals so that resources are available for the most ill patients.